11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Turku University Hospital · Turku PET Centre · +9 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
695
total citations
- FWCI
- 51.58
- Percentile
- 100%
- References
- 38
Citations per year
Authors
17Topics & keywords
Topics
Keywords
- Placebo
- Medicine
- Internal medicine
- Pittsburgh compound B
- Alzheimer's disease
- Gastroenterology
- Nuclear medicine
- Pathology
No related works found for this paper.